Euthymics is a reprise of the top executives from Orexigen, Anthony McKinney (Chief Operating Officer), Gary Tollefson (CEO) and Frank Bymaster (VP, Neuroscience). In July 2010 Euthymics closed a $24m round led by Novartis Venture Fund and Venture Investors. Hambrecht & Quist Capital Management and GBS Venture Partners joined as well. Euthymics has moved into premises in Cambridge Massachusetts and will initiate a phase II/III trial in major depression in first half 2011.
| Website | https://www.euthymics.com |
| Employees | 1 (0 on RocketReach) |
| Founded | 2009 |
| Phone | +1 617-758-0300 |
| Technologies |
JavaScript
,
HTML
,
PHP
+36 more
(view full list)
|
| Industry | Biotechnology, Drug Stores & Pharmacies, Neuropsychiatric drug development, Retail, Science and Engineering, Life Science, Pharmaceutical, Health Care |
| Keywords | Bioscience, Biotechnology, Pharmaceutical, Drug Development, Neuroscience, Clinical Trials, Biotech, Therapeutics, Life Sciences, Venture Capital, Biopharma, Healthcare, Pharma, Research, Development, Science, Medicine, Health |
| SIC | SIC Code 51 Companies, SIC Code 512 Companies |
| NAICS | NAICS Code 42 Companies, NAICS Code 424 Companies, NAICS Code 4242 Companies, NAICS Code 42421 Companies |
Looking for a particular Euthymics Bioscience, Inc. employee's phone or email?
Euthymics Bioscience, Inc. Questions
The NAICS codes for Euthymics Bioscience, Inc. are [42, 424, 4242, 42421].
The SIC codes for Euthymics Bioscience, Inc. are [51, 512].
Related Companies
